T1	Participants 54 106	patients with chronic obstructive pulmonary disease.
T2	Participants 247 306	patients with chronic obstructive pulmonary disease (COPD).
T3	Participants 446 465	patients with COPD.
T4	Participants 499 511	204 patients
T5	Participants 2258 2277	patients with COPD.
